Get the Stockscreener App
104.08
1.33%
-1.40
After Hours:
104.09
0.01
+0.01%
Mesa Laboratories Inc stock is traded at $104.08, with a volume of 559.04K.
It is down -1.33% in the last 24 hours and up +7.89% over the past month.
Mesa Laboratories Inc manufactures life sciences tools and critical quality control solutions. It operates in four divisions: i) Sterilization and Disinfection Control, which manufactures and sells biological, chemical, and cleaning indicators used to assess the effectiveness of sterilization, decontamination, disinfection, and cleaning processes. ii) Clinical Genomics division develops, manufactures, and sells sensitive, low-cost, high-throughput genetic analysis tools and related consumables. iii) The Biopharmaceutical Development division develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. iv) The Calibration Solutions division develops, manufactures, sells, and services quality control products.
See More
Previous Close:
$105.48
Open:
$106.72
24h Volume:
559.04K
Relative Volume:
3.58
Market Cap:
$575.03M
Revenue:
$249.13M
Net Income/Loss:
$6.71M
P/E Ratio:
86.19
EPS:
1.2076
Net Cash Flow:
$39.58M
1W Performance:
-4.04%
1M Performance:
+7.89%
6M Performance:
+33.73%
1Y Performance:
+7.19%
1-Day Range:
$101.79
$107.79
1-Week Range:
$101.79
$113.99
52-Week Range:
$55.45
$113.99
Mesa Laboratories Inc Stock (MLAB) Company Profile
Name
Mesa Laboratories Inc
Sector
Phone
(303) 987-8000
Address
12100 W 6TH AVE, LAKEWOOD
Compare MLAB vs COHR, KEYS, GRMN, TDY, MKSI
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MLAB
Mesa Laboratories Inc
|
104.08 | 582.77M | 249.13M | 6.71M | 39.58M | 1.2076 |
COHR
Coherent Corp
|
413.84 | 75.33B | 6.60B | 452.58M | -538.24M | 2.0946 |
KEYS
Keysight Technologies Inc
|
356.94 | 59.93B | 6.09B | 1.07B | 1.36B | 6.0693 |
GRMN
Garmin Ltd
|
238.17 | 45.92B | 7.46B | 1.74B | 1.45B | 8.9685 |
TDY
Teledyne Technologies Inc
|
628.34 | 29.00B | 6.22B | 933.70M | 1.05B | 19.76 |
MKSI
Mks Inc
|
375.32 | 24.02B | 4.07B | 328.00M | 380.00M | 4.7842 |
Mesa Laboratories Inc Stock (MLAB) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-07-25 | Upgrade | Wells Fargo | Underweight → Equal Weight |
| Aug-28-24 | Initiated | Wells Fargo | Underweight |
| Jan-04-24 | Upgrade | Evercore ISI | In-line → Outperform |
| Jan-04-21 | Downgrade | Evercore ISI | Outperform → In-line |
| Nov-10-20 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Oct-02-20 | Initiated | JP Morgan | Neutral |
| Dec-04-19 | Initiated | Jefferies | Buy |
| Aug-26-19 | Initiated | Evercore ISI | Outperform |
| Jun-10-16 | Downgrade | Sidoti | Buy → Neutral |
View All
Mesa Laboratories Inc Stock (MLAB) Latest News
Mesa Laboratories appoints Lyndsey Crennen as chief accounting officer - Investing.com
Mesa Laboratories Promotes Lyndsey Crennen to Chief Accounting Officer - TipRanks
Lyndsey Crennen named Chief Accounting Officer at Mesa - TradingView
Mesa Laboratories (MLAB) appoints Lyndsey Crennen Chief Accounting Officer - Stock Titan
MLAB Q1 2026 Earnings: EPS Misses Estimates by Significant Margin, Stock DeclinesRevenue Breakdown Analysis - newsline.com
Mesa Laboratories (MLAB) Sees Modest Gains Amid Consolidation Above Key SupportWedge Breakout - newsline.com
MLAB Q1 2026 Earnings: Significant EPS Miss Amid Negative SurpriseFinancial Data - newsline.com
Mesa Laboratories Stock Slides 4.8%: Key Support Level in FocusHull Moving Average - newsline.com
3 Stocks Estimated To Be Trading 16.4% To 42% Below Intrinsic Value - simplywall.st
MLAB Q1 2026 Earnings: Significant EPS Miss Amidst Operational ChallengesEarnings Whisper Number - newsline.com
Mesa Laboratories Inc. (MLAB) Declines 4.19% as Shares Test Key Support LevelsSector ETF Flow - newsline.com
Mesa Laboratories : Annual Report for Fiscal Year Ending 03-31, 2026 (Form 10-K) - marketscreener.com
Mesa Laboratories, Inc. 2026 Annual Report: Business Overview, Strategy, Segments, and Key Risk Factors - Minichart
Tranche Update on Mesa Laboratories, Inc.'s Equity Buyback Plan announced on November 10, 2005. - marketscreener.com
Mesa Laboratories (NASDAQ: MLAB) outlines global segments, GKE deal and key risks - Stock Titan
MLAB Q1 2026 Earnings: EPS Soars Past Estimates by 695%, Revenue Data UnavailableProfit Guidance Range - The Legal Advocate
Mesa Laboratories (MLAB) Slips 1.05% as Stock Nears Support ZoneStock Buy Zone - The Legal Advocate
Jefferies raises Mesa Laboratories stock price target on CEO outlook By Investing.com - Investing.com Nigeria
Jefferies raises Mesa Laboratories stock price target on CEO outlook - Investing.com
Mesa Labs 4Q Rev $63.7M >MLAB - Moomoo
Mesa Labs 4Q Loss $4.14M >MLAB - Moomoo
Mesa Labs earnings beat by $1.76, revenue fell short of estimates - Investing.com Canada
Why Mesa Laboratories Stock Is Getting Hit With a Huge Sell-Off Today - The Motley Fool
Why Mesa Laboratories Stock Is Getting Hit With a Huge Sell-Off Today - The Motley Fool
Mesa Laboratories' Stock Slips as 4Q Growth Misses Targets - Moomoo
12 Health Care Stocks Moving In Wednesday's Intraday Session - Benzinga
Mesa Labs 4Q Loss/Shr 75c >MLAB - Moomoo
Is Mesa Laboratories (MLAB) Modestly Undervalued Despite Q4 FY26 - GuruFocus
Mesa Laboratories Inc reports results for the quarter ended March 31Earnings Summary - TradingView
Press Release: Mesa Labs Announces Fourth Quarter and Fiscal Year 2026 Results - Moomoo
MESA LABORATORIES ($MLAB) Releases Q4 2026 Earnings - Quiver Quantitative
Mesa Labs: Fiscal Q4 Earnings Snapshot - marketscreener.com
Mesa Laboratories reports FY26 revenue $249.1M, operating income $18.5M, AOI ex-unusual $63.5M - TradingView
Mesa Laboratories (NASDAQ: MLAB) grows FY26 revenue 3.4% as margins expand - Stock Titan
Mesa Labs Announces Fourth Quarter and Fiscal Year 2026 Results - GlobeNewswire
Mesa Laboratories Inc. (MLAB) Q1 2026 Earnings: Strong EPS Surprise of 130% Amid Quiet Revenue DisclosureEPS Miss Report - The Legal Advocate
MLAB Q1 2026 Earnings: Significant EPS Beat Driven by Strong Operational PerformanceRevenue Warning Signal - The Legal Advocate
MLAB Q1 2026 Earnings: Earnings Per Share Surges Past Estimates by Over 130%High Growth Earnings - newsline.com
Mesa Laboratories Inc. (MLAB) Q1 2026 Earnings: Stellar EPS Surprise of 130% Drives Optimism Amidst Quiet Revenue PeriodRevenue Growth Report - Newser
MLAB Q1 2026 Earnings: EPS Surges 130% Above Estimates Amid Operational Efficiency GainsRevenue Inflection Point - newsline.com
Mesa Labs Stock Pops Before the Date Investors Can’t Ignore - Bez Kabli
MLAB Q4'25 Earnings: revenue estimate is 65.21M USD - TradingView
Mesa Laboratories (MLAB) CEO awarded 35,236 restricted stock units in Form 4/A - Stock Titan
Mesa Laboratories stock (US59064R1095): Precision tools for life sciences - AD HOC NEWS
MLAB Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
MLAB Mesa Laboratories posts 130% earnings beat, but MLAB shares fall 1.39% despite strong 11.5% revenue growth.Shared Momentum Picks - Newser
Mesa Laboratories Inc at JPMorgan Healthcare Conference Transcript - GuruFocus
Mesa Laboratories, Inc. to Announce Fourth Quarter and Full Fiscal Year Results on May 27, 2026 - Weekly Voice
Mesa Laboratories, Inc. Scheduled to Release Q4 and Fiscal Year 2026 Financial Results on May 27, 2026 - Quiver Quantitative
Mesa Labs sets May 27 release for full-year and Q4 results - Stock Titan
Mesa Laboratories names new CEO - MSN
Mesa Laboratories Inc Stock (MLAB) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.92%
0.42%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):